Cargando…
Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
The hypothalamic paraventricular nucleus (PVN) is an important site where an interaction between circulating angiotensin (Ang) and mineralocorticoid receptor (MR) activity may modify sympathetic nerve activity (SNA) to influence long-term elevation of blood pressure. We examined in conscious Ang II-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982587/ https://www.ncbi.nlm.nih.gov/pubmed/33762970 http://dx.doi.org/10.3389/fphys.2021.640373 |
_version_ | 1783667751224606720 |
---|---|
author | Burke, Sandra L. Barzel, Benjamin Jackson, Kristy L. Gueguen, Cindy Young, Morag J. Head, Geoffrey A. |
author_facet | Burke, Sandra L. Barzel, Benjamin Jackson, Kristy L. Gueguen, Cindy Young, Morag J. Head, Geoffrey A. |
author_sort | Burke, Sandra L. |
collection | PubMed |
description | The hypothalamic paraventricular nucleus (PVN) is an important site where an interaction between circulating angiotensin (Ang) and mineralocorticoid receptor (MR) activity may modify sympathetic nerve activity (SNA) to influence long-term elevation of blood pressure. We examined in conscious Ang II-treated rabbits, the effects on blood pressure and tonic and reflex renal SNA (RSNA) of microinjecting into the PVN either RU28318 to block MR, losartan to block Ang (AT(1)) receptors or muscimol to inhibit GABA(A) receptor agonist actions. Male rabbits received a moderate dose of Ang II (24 ng/kg/min subcutaneously) for 3 months (n = 13) or sham treatment (n = 13). At 3 months, blood pressure increased by +19% in the Ang II group compared to 10% in the sham (P = 0.022) but RSNA was similar. RU28318 lowered blood pressure in both Ang II and shams but had a greater effect on RSNA and heart rate in the Ang II-treated group (P < 0.05). Losartan also lowered RSNA, while muscimol produced sympatho-excitation in both groups. In Ang II-treated rabbits, RU28318 attenuated the blood pressure increase following chemoreceptor stimulation but did not affect responses to air jet stress. In contrast losartan and muscimol reduced blood pressure and RSNA responses to both hypoxia and air jet. While neither RU28318 nor losartan changed the RSNA baroreflex, RU28318 augmented the range of the heart rate baroreflex by 10% in Ang II-treated rabbits. Muscimol, however, augmented the RSNA baroreflex by 11% in sham animals and none of the treatments altered baroreflex sensitivity. In conclusion, 3 months of moderate Ang II treatment promotes activation of reflex RSNA principally via MR activation in the PVN, rather than via activation of AT(1) receptors. However, the onset of hypertension is independent of both. Interestingly, the sympatho-excitatory effects of muscimol in both groups suggest that overall, the PVN regulates a tonic sympatho-inhibitory influence on blood pressure control. |
format | Online Article Text |
id | pubmed-7982587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79825872021-03-23 Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension Burke, Sandra L. Barzel, Benjamin Jackson, Kristy L. Gueguen, Cindy Young, Morag J. Head, Geoffrey A. Front Physiol Physiology The hypothalamic paraventricular nucleus (PVN) is an important site where an interaction between circulating angiotensin (Ang) and mineralocorticoid receptor (MR) activity may modify sympathetic nerve activity (SNA) to influence long-term elevation of blood pressure. We examined in conscious Ang II-treated rabbits, the effects on blood pressure and tonic and reflex renal SNA (RSNA) of microinjecting into the PVN either RU28318 to block MR, losartan to block Ang (AT(1)) receptors or muscimol to inhibit GABA(A) receptor agonist actions. Male rabbits received a moderate dose of Ang II (24 ng/kg/min subcutaneously) for 3 months (n = 13) or sham treatment (n = 13). At 3 months, blood pressure increased by +19% in the Ang II group compared to 10% in the sham (P = 0.022) but RSNA was similar. RU28318 lowered blood pressure in both Ang II and shams but had a greater effect on RSNA and heart rate in the Ang II-treated group (P < 0.05). Losartan also lowered RSNA, while muscimol produced sympatho-excitation in both groups. In Ang II-treated rabbits, RU28318 attenuated the blood pressure increase following chemoreceptor stimulation but did not affect responses to air jet stress. In contrast losartan and muscimol reduced blood pressure and RSNA responses to both hypoxia and air jet. While neither RU28318 nor losartan changed the RSNA baroreflex, RU28318 augmented the range of the heart rate baroreflex by 10% in Ang II-treated rabbits. Muscimol, however, augmented the RSNA baroreflex by 11% in sham animals and none of the treatments altered baroreflex sensitivity. In conclusion, 3 months of moderate Ang II treatment promotes activation of reflex RSNA principally via MR activation in the PVN, rather than via activation of AT(1) receptors. However, the onset of hypertension is independent of both. Interestingly, the sympatho-excitatory effects of muscimol in both groups suggest that overall, the PVN regulates a tonic sympatho-inhibitory influence on blood pressure control. Frontiers Media S.A. 2021-03-08 /pmc/articles/PMC7982587/ /pubmed/33762970 http://dx.doi.org/10.3389/fphys.2021.640373 Text en Copyright © 2021 Burke, Barzel, Jackson, Gueguen, Young and Head. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Burke, Sandra L. Barzel, Benjamin Jackson, Kristy L. Gueguen, Cindy Young, Morag J. Head, Geoffrey A. Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension |
title | Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension |
title_full | Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension |
title_fullStr | Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension |
title_full_unstemmed | Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension |
title_short | Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension |
title_sort | role of mineralocorticoid and angiotensin type 1 receptors in the paraventricular nucleus in angiotensin-induced hypertension |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982587/ https://www.ncbi.nlm.nih.gov/pubmed/33762970 http://dx.doi.org/10.3389/fphys.2021.640373 |
work_keys_str_mv | AT burkesandral roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension AT barzelbenjamin roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension AT jacksonkristyl roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension AT gueguencindy roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension AT youngmoragj roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension AT headgeoffreya roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension |